These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 15319471)
1. Susceptibility to astrocytoma in mice mutant for Nf1 and Trp53 is linked to chromosome 11 and subject to epigenetic effects. Reilly KM; Tuskan RG; Christy E; Loisel DA; Ledger J; Bronson RT; Smith CD; Tsang S; Munroe DJ; Jacks T Proc Natl Acad Sci U S A; 2004 Aug; 101(35):13008-13. PubMed ID: 15319471 [TBL] [Abstract][Full Text] [Related]
2. Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects. Reilly KM; Loisel DA; Bronson RT; McLaughlin ME; Jacks T Nat Genet; 2000 Sep; 26(1):109-13. PubMed ID: 10973261 [TBL] [Abstract][Full Text] [Related]
3. Nf1 expression is dependent on strain background: implications for tumor suppressor haploinsufficiency studies. Hawes JJ; Tuskan RG; Reilly KM Neurogenetics; 2007 Apr; 8(2):121-30. PubMed ID: 17216419 [TBL] [Abstract][Full Text] [Related]
4. Scram1 is a modifier of spinal cord resistance for astrocytoma on mouse Chr 5. Amlin-Van Schaick J; Kim S; Broman KW; Reilly KM Mamm Genome; 2012 Apr; 23(3-4):277-85. PubMed ID: 22160242 [TBL] [Abstract][Full Text] [Related]
5. The importance of genome architecture in cancer susceptibility: location, location, location. Reilly KM Cell Cycle; 2004 Nov; 3(11):1378-82. PubMed ID: 15492507 [TBL] [Abstract][Full Text] [Related]
6. Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma. Zhu Y; Guignard F; Zhao D; Liu L; Burns DK; Mason RP; Messing A; Parada LF Cancer Cell; 2005 Aug; 8(2):119-30. PubMed ID: 16098465 [TBL] [Abstract][Full Text] [Related]
7. Arlm1 is a male-specific modifier of astrocytoma resistance on mouse Chr 12. Amlin-Van Schaick JC; Kim S; DiFabio C; Lee MH; Broman KW; Reilly KM Neuro Oncol; 2012 Feb; 14(2):160-74. PubMed ID: 22234937 [TBL] [Abstract][Full Text] [Related]
8. Increased neurofibromatosis 1 gene expression in astrocytic tumors: positive regulation by p21-ras. Gutmann DH; Giordano MJ; Mahadeo DK; Lau N; Silbergeld D; Guha A Oncogene; 1996 May; 12(10):2121-7. PubMed ID: 8668337 [TBL] [Abstract][Full Text] [Related]
9. The molecular and cell biology of pediatric low-grade gliomas. Chen YH; Gutmann DH Oncogene; 2014 Apr; 33(16):2019-26. PubMed ID: 23624918 [TBL] [Abstract][Full Text] [Related]
10. Chr 19(A/J) modifies tumor resistance in a sex- and parent-of-origin-specific manner. Walrath JC; Fox K; Truffer E; Gregory Alvord W; Quiñones OA; Reilly KM Mamm Genome; 2009 Apr; 20(4):214-23. PubMed ID: 19347398 [TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid proteomic analysis reveals dysregulation of methionine aminopeptidase-2 expression in human and mouse neurofibromatosis 1-associated glioma. Dasgupta B; Yi Y; Hegedus B; Weber JD; Gutmann DH Cancer Res; 2005 Nov; 65(21):9843-50. PubMed ID: 16267007 [TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity occurs via mitotic recombination in Trp53+/- mice and associates with mammary tumor susceptibility of the BALB/c strain. Blackburn AC; McLary SC; Naeem R; Luszcz J; Stockton DW; Donehower LA; Mohammed M; Mailhes JB; Soferr T; Naber SP; Otis CN; Jerry DJ Cancer Res; 2004 Aug; 64(15):5140-7. PubMed ID: 15289317 [TBL] [Abstract][Full Text] [Related]
13. Mice with GFAP-targeted loss of neurofibromin demonstrate increased axonal MET expression with aging. Su W; Xing R; Guha A; Gutmann DH; Sherman LS Glia; 2007 May; 55(7):723-33. PubMed ID: 17348023 [TBL] [Abstract][Full Text] [Related]
14. Functional characterization of a BRAF insertion mutant associated with pilocytic astrocytoma. Eisenhardt AE; Olbrich H; Röring M; Janzarik W; Anh TN; Cin H; Remke M; Witt H; Korshunov A; Pfister SM; Omran H; Brummer T Int J Cancer; 2011 Nov; 129(9):2297-303. PubMed ID: 21190184 [TBL] [Abstract][Full Text] [Related]
15. Up-regulation of specific NF 1 gene transcripts in sporadic pilocytic astrocytomas. Platten M; Giordano MJ; Dirven CM; Gutmann DH; Louis DN Am J Pathol; 1996 Aug; 149(2):621-7. PubMed ID: 8702000 [TBL] [Abstract][Full Text] [Related]
16. Real-time PCR analysis of candidate imprinted genes on mouse chromosome 11 shows balanced expression from the maternal and paternal chromosomes and strain-specific variation in expression levels. Tuskan RG; Tsang S; Sun Z; Baer J; Rozenblum E; Wu X; Munroe DJ; Reilly KM Epigenetics; 2008; 3(1):43-50. PubMed ID: 18188004 [TBL] [Abstract][Full Text] [Related]
18. Neurofibroma-associated growth factors activate a distinct signaling network to alter the function of neurofibromin-deficient endothelial cells. Munchhof AM; Li F; White HA; Mead LE; Krier TR; Fenoglio A; Li X; Yuan J; Yang FC; Ingram DA Hum Mol Genet; 2006 Jun; 15(11):1858-69. PubMed ID: 16648142 [TBL] [Abstract][Full Text] [Related]
19. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications. Gottfried ON; Viskochil DH; Couldwell WT Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723 [TBL] [Abstract][Full Text] [Related]
20. Establishment and characterization of a novel malignant astrocytoma cell line derived from a tumor removed in a patient with neurofibromatosis type 1. Kurimoto M; Hirashima Y; Ogiichi T; Hamada H; Kamiyama H; Endo S J Neurosurg; 2001 Feb; 94(2):301-8. PubMed ID: 11213969 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]